Impact of gestational nicotine exposure on intrauterine and fetal infection in a rodent model

Biology of Reproduction

Volumn 96, Issue 5, 2017, Pages 1071-1084

  Von Chamier, Maria ^a   Reyes, Leticia ^a,b   Hayward, Linda F ^a   Brown, Mary B ^a  

^a University of Florida   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Infection; Inflammation; Nicotine; Placental pathology; Pregnancy; Rodent model

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; NICOTINE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR; CYTOKINE; NICOTINIC AGENT;

AMNION FLUID; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; CYTOKINE RELEASE; FETUS; INFECTION RISK; INTRAUTERINE INFECTION; MYCOPLASMA PULMONIS; NONHUMAN; PATHOGEN LOAD; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; RISK FACTOR; ANIMAL; BACTERIAL COUNT; BACTERIAL LOAD; FEMALE; FETUS DISEASE; INFLAMMATION; METABOLISM; MICROBIOLOGY; MYCOPLASMOSIS; PATHOLOGY; PLACENTA; PREGNANCY; PREGNANCY COMPLICATION; SPRAGUE DAWLEY RAT;

AMNIOTIC FLUID; ANIMALS; BACTERIAL LOAD; COLONY COUNT, MICROBIAL; CYTOKINES; FEMALE; FETAL DISEASES; INFLAMMATION; MYCOPLASMA INFECTIONS; MYCOPLASMA PULMONIS; NICOTINE; NICOTINIC AGONISTS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 85021370564     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1093/biolre/iox025     Document Type: Article

References (81)

1. Harding R, Maritz G. Maternal and fetal origins of lung disease in adulthood. Semin Fetal Neonatal Med 2012; 17:67-72.
2. Mund M, Louwen F, Klingelhoefer D, Gerber A. Smoking and pregnancya review on the first major environmental risk factor of the unborn. Int J Environ Res Public Health 2013; 10:6485-6499.
3. Andres RL, Day MC. Perinatal complications associated with maternal tobacco use. Semin Neonatol 2000; 5:231-241.
4. Hayashi K, Matsuda Y, Kawamichi Y, Shiozaki A, Saito S. Smoking during pregnancy increases risks of various obstetric complications: a case-cohort study of the Japan Perinatal Registry Network database. J Epidemiol 2011; 21:61-66.
5. McEvoy CT, Spindel ER. Pulmonary effects of maternal smoking on the fetus and child: Effects on lung development, respiratory morbidities, and life long lung health. Paediatr Respir Rev 2016; 21:27-33.
6. Jauniaux E, Burton GJ. Morphological and biological effects of maternal exposure to tobacco smoke on the fetoplacental unit. Early Hum Dev 2007; 83:699-706.
7. Chen M, Wang T, Liao ZX, Pan XL, Feng YH, Wang H. Nicotine-induced prenatal overexposure to maternal glucocorticoid and intrauterine growth retardation in rat. Exp Toxicol Pathol 2007; 59:245-251.
8. Holloway AC, Salomon A, Soares MJ, Garnier V, Raha S, Sergent F, Nicholson CJ, Feige JJ, Benharouga M, Alfaidy N. Characterization of the adverse effects of nicotine on placental development: in vivo and in vitro studies. Am J Physiol Endocrinol Metab 2014; 306:E443-E456.
9. Romani F, Lanzone A, Tropea A, Tiberi F, Catino S, Apa R. Nicotine and cotinine affect the release of vasoactive factors by trophoblast cells and human umbilical vein endothelial cells. Placenta 2011; 32: 153-160.
10. Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2015; 12:CD010078.
11. Coleman-Cowger VH, Anderson BL, Mahoney J, Schulkin J. Smoking cessation during pregnancy and postpartum: practice patterns among obstetrician-gynecologists. JAddict Med 2014; 8:14-24.
12. Aubin HJ, Luquiens A, Berlin I. Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. Br JClin Pharmacol 2014; 77:324-336.
13. Brose LS, McEwen A, West R. Association between nicotine replacement therapy use in pregnancy and smoking cessation. Drug Alcohol Depend 2013; 132:660-664.
14. Myung SK, Ju W, Jung HS, Park CH, Oh SW, Seo H, Kim H. Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis. Bjog 2012; 119:1029-1039.
15. Berlin I, Grange G, Jacob N, Tanguy ML. Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy. BMJ 2014; 348:g1622.
16. Slotkin TA. If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents? Neurotoxicol Teratol 2008; 30:1-19.
17. Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control 2010; 19:98-103.
18. Pokhrel P, Little MA, Fagan P, Kawamoto CT, Herzog TA. Correlates of use of electronic cigarettes versus nicotine replacement therapy for help with smoking cessation. Addict Behav 2014; 39:1869-1873.
19. Ayers JW, Ribisl KM, Brownstein JS. Tracking the rise in popularity of electronic nicotine delivery systems (electronic cigarettes) using search query surveillance. Am JPrev Med 2011; 40:448-453.
20. Baeza-Loya S, Viswanath H, Carter A, Molfese DL, Velasquez KM, Baldwin PR, Thompson-Lake DG, Sharp C, Fowler JC, De La Garza R, 2nd, Salas R. Perceptions about e-cigarette safety may lead to e-smoking during pregnancy. Bull Menninger Clin 2014; 78:243-252.
21. Benowitz NL. Emerging nicotine delivery products: Implications for public health. Ann Am Thorac Soc 2014; 11:231-235.
22. Choi K, Forster J. Characteristics associated with awareness, perceptions, and use of electronic nicotine delivery systems among young US Midwestern adults. Am JPublic Health 2013; 103:556-561.
23. Choi K, Forster JL. Beliefs and experimentation with electronic cigarettes: A prospective analysis among young adults. Am J Prev Med 2014; 46: 175-178.
24. Ashford K, Wiggins A, Butler K, Ickes M, Rayens MK, Hahn E. E-cigarette use and perceived harm among women of childbearing age who reported tobacco use during the past year. Nurs Res 2016; 65:408-414.
25. Sieminska A, Jassem E. The many faces of tobacco use among women. Med Sci Monit 2014; 20:153-162.
26. Goniewicz ML, Hajek P, McRobbie H. Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction 2014; 109:500-507.
27. Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl). 2014; 231:401-407.
28. Talih S, Balhas Z, Eissenberg T, Salman R, Karaoghlanian N, El Hellani A, Baalbaki R, Saliba N, Shihadeh A. Effects of user puff topography, device voltage, and liquid nicotine concentration on electronic cigarette nicotine yield: measurements and model predictions. Nicotine Tob Res 2015; 17:150-157.
29. Shihadeh A, Eissenberg T. Electronic cigarette effectiveness and abuse liability: predicting and regulating nicotine flux. Nicotine Tob Res 2015; 17:158-162.
30. Hajek P, Goniewicz ML, Phillips A, Myers Smith K, West O, McRobbie H. Nicotine intake from electronic cigarettes on initial use and after 4 weeks ofregular use. Nicotine Tob Res 2015; 17:175-179.
31. Ramoa CP, Hiler MM, Spindle TR, Lopez AA, Karaoghlanian N, Lipato T, Breland AB, Shihadeh A, Eissenberg T. Electronic cigarette nicotine delivery can exceed that of combustible cigarettes: a preliminary report. Tob Control 2016; 25:e6-e9.
32. Berger A, Witt A, Haiden N, Kretzer V, Heinze G, Kohlhauser C. Mi-crobial invasion of the amniotic cavity at birth is associated with adverse short-term outcome of preterm infants. J Perinat Med 2003; 31: 115-121.
33. Goldenberg RL, Andrews WW, Faye-Petersen OM, Goepfert AR, Cliver SP, Hauth JC. The Alabama Preterm Birth Study: intrauterine infection and placental histologic findings in preterm births of males and females less than 32 weeks. Am JObstet Gynecol 2006; 195:1533-1537.
34. Goncalves LF, Chaiworapongsa T, Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002; 8:3-13.
35. Romero R, Espinoza J, Kusanovic JP, Gotsch F, Hassan S, Erez O, Chai-worapongsa T, Mazor M. The preterm parturition syndrome. Bjog 2006; 113(Suppl 3):17-42.
36. Institute of medicine (U.S.) committee on understanding premature birth and assuring healthy outcomes. In: Behrman RE, Butler AS (eds.) Preterm Birth: Causes, Consequences, and Prevention. Washington, DC: National Academies Press (US); 2007:1-792.
37. Aliyu MH, Weldeselasse H, August EM, Keith LG, Salihu HM. Cigarette smoking and fetal morbidity outcomes in a large cohort of HIV-infected mothers. Nicotine Tob Res 2013; 15:177-184.
38. Boychuk CR, Fuller DD, Hayward LF. Sex differences in heart rate variability during sleep following prenatal nicotine exposure in rat pups. Behav Brain Res 2011; 219:82-91.
39. Boychuk CR, Hayward LF. Prenatal nicotine exposure alters postnatal car-diorespiratory integration in young male but not female rats. Exp Neurol 2011; 232:212-221.
40. Fuller DD, Dougherty BJ, Sandhu MS, Doperalski NJ, Reynolds CR, Hayward LF. Prenatal nicotine exposure alters respiratory long-term facilitation in neonatal rats. Respir Physiol Neurobiol 2009; 169:333-337.
41. Hussein J, Farkas S, MacKinnon Y, Ariano RE, Sitar DS, Hasan SU. Nicotine dose-concentration relationship and pregnancy outcomes in rat: biologic plausibility and implications for future research. Toxicol Appl Pharmacol 2007; 218:1-10.
42. Brown MB, Peltier M, Hillier M, Crenshaw B, Reyes L. Genital mycoplasmosis in rats: a model for intrauterine infection. Am J Reprod Immunol 2001; 46:232-241.
43. Brown MB, Steiner DA. Experimental genital mycoplasmosis: time of infection influences pregnancy outcome. Infect Immun 1996; 64:23152321.
44. Peltier MR, Richey LJ, Brown MB. Placental lesions caused by experimental infection of Sprague-Dawley rats with Mycoplasma pulmonis. Am J Reprod Immunol 2003; 50:254-262.
45. Reyes L, Shelton M, Riggs M, Brown MB. Rat strains differ in susceptibility to maternal and fetal infection with Mycoplasma pulmonis. Am J Reprod Immunol 2004; 51:211-219.
46. Riggs MA, Maunsell FP, Reyes L, Brown MB. Hematogenous infection of Sprague-Dawley rats with Mycoplasma pulmonis: development of a model for maternal and fetal infection. Am J Obstet Gynecol 2008; 198: 318.e311-e317.
47. Wickstrom R. Effects of nicotine during pregnancy: human and experimental evidence. Curr Neuropharmacol 2007; 5:213-222.
48. Bublitz MH, Stroud LR. Maternal smoking during pregnancy and offspring brain structure and function: review and agenda for future research. Nicotine Tob Res 2012; 14:388-397.
49. Cornelius MD, Day NL. Developmental consequences of prenatal tobacco exposure. Curr Opin Neurol 2009; 22:121-125.
50. Leslie FM. Multigenerational epigenetic effects of nicotine on lung function. BMC Med 2013; 11:27.
51. Maritz GS. Nicotine and lung development. Birth Defects Res C Embryo Today 2008; 84:45-53.
52. Spindel ER, McEvoy CT. The role of nicotine in the effects of maternal smoking during pregnancyon lung development and childhood respiratory disease: Implications for dangers of e-cigarettes. Am J Respir Crit Care Med 2016; 193:486-494.
53. Wong MK, Barra NG, Alfaidy N, Hardy DB, Holloway AC. Adverse effects of perinatal nicotine exposure on reproductive outcomes. Reproduction 2015; 150:R185-R193.
54. Furukawa S, Kuroda Y, Sugiyama A. A comparison of the histological structure of the placenta in experimental animals. JToxicol Pathol 2014; 27:11-18.
55. Burd I, Balakrishnan B, Kannan S. Models of fetal brain injury, intrauterine inflammation, and preterm birth. Am J Reprod Immunol 2012; 67:287-294.
56. Elovitz MA, Mrinalini C. Animal models of preterm birth. Trends Endocrinol Metab 2004; 15:479-487.
57. Kemp MW, Saito M, Newnham JP, Nitsos I, Okamura K, Kallapur SG. Preterm birth, infection, and inflammation advances from the study of animal models. Reprod Sci 2010; 17:619-628.
58. Soares MJ, Chakraborty D, Karim Rumi MA, Konno T, Renaud SJ. Rat placentation: an experimental model for investigating the hemochorial maternal-fetal interface. Placenta 2012; 33:233-243.
59. Burton A, Kizhner O, Brown MB, Peltier MR. Effect of experimental genital mycoplasmosis on gene expression in the fetal brain. J Reprod Immunol 2012; 93:9-16.
60. Busch K, Naglic T. Natural uterine Mycoplasma pulmonis infection in female rats. Vet Med (Praha) 1995; 40:253-255.
61. Cox NR, Davidson MK, Davis JK, Lindsey JR, Cassell GH. Natural mycoplasmal infections in isolator-maintained LEW/Tru rats. Lab Anim Sci 1988; 38:381-388.
62. Viscardi RM. Ureaplasma species: role in neonatal morbidities and outcomes. Arch Dis Child Fetal Neonatal Ed 2014; 99:F87-F92.
63. Capoccia R, Greub G, Baud D. Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes. Curr Opin Infect Dis 2013; 26:231-240.
64. DiGiulio DB. Diversity of microbes in amniotic fluid. Semin Fetal Neonatal Med 2012; 17:2-11.
65. Waites KB, Schelonka RL, Xiao L, Grigsby PL, Novy MJ. Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis. Semin Fetal Neonatal Med 2009; 14:190-199.
66. Peltier MR, Brown MB. Experimental genital mycoplasmosis causes increased levels of mRNA for IL-6 and TNF-alpha in the placenta. Am J Reprod Immunol 2005; 53:189-198.
67. Elovitz MA, Mrinalini C, Sammel MD. Elucidating the early signal trans-duction pathways leading to fetal brain injury in preterm birth. Pediatr Res 2006; 59:50-55.
68. Li L, Shi L, Yang X, Ren L, Yang J, Lin Y. Role of invariant natural killer T cells in lipopolysaccharide-induced pregnancy loss. Cell Immunol 2013; 286:1-10.
69. Murphy SP, Fast LD, Hanna NN, Sharma S. Uterine NK cells mediate inflammation-induced fetal demise in IL-10-null mice. J Immunol 2005; 175:4084-4090.
70. Robertson SA, Skinner RJ, Care AS. Essential role for IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J Immunol 2006; 177:4888-4896.
71. Brown MB, von Chamier M, Allam AB, Reyes L. M1/M2 macrophage polarity in normal and complicated pregnancy. Front Immunol 2014; 5:606.
72. Svensson-Arvelund J, Ernerudh J. The role of macrophages in promoting and maintaining homeostasis at the fetal-maternal interface. AmJReprod Immunol 2015; 74:100-109.
73. Svensson-Arvelund J, Ernerudh J, Buse E, Cline JM, Haeger JD, Dixon D, Markert UR, Pfarrer C, De Vos P, Faas MM. The placenta in toxicology. Part II: Systemic and local immune adaptations in pregnancy. Toxicol Pathol 2014; 42:327-338.
74. Svensson-Arvelund J, Mehta RB, Lindau R, Mirrasekhian E, Rodriguez-Martinez H, Berg G, Lash GE, Jenmalm MC, Ernerudh J. The human fetal placenta promotes tolerance against the semiallogeneic fetus by inducing regulatory T cells and homeostatic M2 macrophages. J Immunol 2015; 194:1534-1544.
75. Kunze M, Klar M, Morfeld CA, Thorns B, Schild RL, Markfeld- Erol F, Rasenack R, Proempeler H, Hentschel R, Schaefer WR. Cy-tokines in noninvasively obtained amniotic fluid as predictors of fetal inflammatory response syndrome. Am J Obstet Gynecol 2016; 215:96 e91-e98.
76. Romero R, Chaemsaithong P, Korzeniewski SJ, Tarca AL, Bhatti G, Xu Z, Kusanovic JP, Dong Z, Docheva N, Martinez-Varea A, Yoon BH, Hassan SS et al. Clinical chorioamnionitis at term II: the intra-amniotic inflammatory response. J Perinat Med 2016; 44: 5-22.
77. Shobokshi A, Shaarawy M. Maternal serum and amniotic fluid cy-tokines in patients with preterm premature rupture of membranes with and without intrauterine infection. Int J Gynaecol Obstet 2002; 79: 209-215.
78. Kobayashi K, Umezawa K, Yasui M. Apoptosis in mouse amniotic epithelium is induced by activated macrophages through the TNF receptor type1/TNF pathway. Biol Reprod 2011; 84:248-254.
79. Dahlgren J, Samuelsson AM, Jansson T, Holmang A. Interleukin-6 in the maternal circulation reaches the rat fetus in mid-gestation. Pediatr Res 2006; 60:147-151.
80. D'Alquen D, Kramer BW, Seidenspinner S, Marx A, Berg D, Groneck P, Speer CP. Activation of umbilical cord endothelial cells and fetal inflammatory response in preterm infants with chorioamnionitis and funisitis. Pediatr Res 2005; 57:263-269.
81. Kemp MW, Molloy TJ, Usuda H, Woodward E, Miura Y, Payne MS, Ireland DJ, Jobe AH, Kallapur SG, Stock SJ, Spiller OB, Newnham JP et al. Outside-in? Acute fetal systemic inflammation in very preterm chronically catheterized sheep fetuses is not driven by cells in the fetal blood. Am J Obstet Gynecol 2016; 214: 281 e281-281 e210.